CCIA
ENZ

Campbell & Co Investment Adviser’s Enzo Biochem, Inc. ENZ Stock Holding History

Campbell & Co Investment Adviser’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-32,342
Closed -$264K – 552
2017
Q4 		$264K Sell
32,342
-5,591
-15% -$53.4K 0.19% 232
2017
Q3 		$397K Buy
37,933
+4,420
+13% +$49.1K 0.32% 107
2017
Q2 		$370K Buy
33,513
+19,188
+134% +$179K 0.34% 91
2017
Q1 		$120K Buy
14,325
+2,812
+24% +$19.8K 0.31% 132
2016
Q4 		$80K Buy
+11,513
New +$73.5K 0.25% 126

Other funds holding ENZ

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Campbell & Co Investment Adviser's ENZ Position: Q1 2018 in Review

Campbell & Co Investment Adviser sold out of Enzo Biochem, Inc. (ENZ) in Q1 2018, closing a stake of 32,342 shares — an estimated $264K sold.

Campbell & Co Investment Adviser first reported a position in ENZ in Q4 2016 and held it in 5 quarters. The position peaked at $397K in Q3 2017. 107 funds tracked by Wall St. Rank hold ENZ as of Q1 2018.

  • Campbell & Co Investment Adviser reported no remaining Enzo Biochem, Inc. position as of Q1 2018 after selling out during the quarter.
  • Campbell & Co Investment Adviser sold 32,342 Enzo Biochem, Inc. shares in Q1 2018, an estimated $264K.
  • Campbell & Co Investment Adviser first reported a position in Enzo Biochem, Inc. in Q4 2016 and held it in 5 quarters.
  • Campbell & Co Investment Adviser's Enzo Biochem, Inc. position peaked at $397K in Q3 2017.
  • 107 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q1 2018.

Based on Campbell & Co Investment Adviser's 13F filing for Q1 2018, filed 4 May 2018.